LMU Klinikum Muenchen AöR

Treatment & access

• Treatments offeredKetamine
• Access routeTrial
• Cost & coverage (registry status)Free within clinical trial
• Websitehttps://www.lmu-klinikum.de

Languages spoken

As stated by the provider on its own website: each language links to the exact page and wording it was verified against.

• Arabic (patient support / interpreting, not the therapy language) “Patient Managers ... Herr Munir Berhanu (العربية/Arabisch) +49 89 4400 75147” Source
• Russian (patient support / interpreting, not the therapy language) “Frau Natalie Kusmina (Русский/Russisch) +49 89 4400 72014” Source

Language information verified 2026-09-06.

About this provider

Compiled from the registry data on this page.

The EU Clinical Trials Information System (CTIS) records LMU Klinikum Muenchen AöR in Munich, Germany, as a site of trial 2024-512478-86-00: a randomized, controlled, double-blinded phase II study of pharmacologic treatment augmentation in chronic depression, sponsored by Universitaetsklinikum Tuebingen AöR. This directory lists the site for ketamine; access is through participation in the trial, and treatment is free within the clinical trial. The CTIS public record is the registry source cited by this entry. The record was last verified on 2026-07-29.

2 more verified providers within 50 km

• München · 0 kmPrivatpraxis für Psychiatrie Vitali Livak — Standort München : Spravato®
• Grafing bei München · 31 kmPraxis für Psychiatrie Vitali Livak — Standort Grafing bei München : Spravato®

See them on the provider map →

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.